ZL-2306

niraparib · Zai Lab (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZL-2306, covering 2021-06-02 to 2023-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient [Phase 3]